Far Fewer Deaths During Omicron for Seniors Treated With Paxlovid
Older patients treated with nirmatrelvir boosted by ritonavir (Paxlovid) for COVID-19 had lower rates of hospitalization and death compared with those not treated with the antiviral during the Omicron wave, according to an observational retrospective cohort study from Israel. Among patients ages 65 and older, the rate of hospitalization due to COVID was 14.7 cases […]